Zheng, Jifang
Zhang, Hejun
Li, Siya
Kang, Zhaoxin
Zheng, Fei
Yao, Qiwei
Zhang, Xueqing
Wu, Ziyi
Wang, Jiezhong
Fang, Weimin
Li, Jiancheng
Chen, Gang
Chen, Yuangui
Chen, Mingqiu
Funding for this research was provided by:
Fujian provincial health and family planning research talent training program (2020GGB009)
the National Natural Science Foundation of China (No. 82173051)
Scientific Research Foundation of Fujian Cancer Hospital (No. 2021YN01)
Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (No. 2020Y2012)
National Clinical Key Specialty Construction Program (No. 2021)
Article History
Received: 11 May 2023
Accepted: 27 November 2023
First Online: 5 December 2023
Declarations
:
: Informed consent was obtained from all subjects involved in the study. The study was conducted in accordance with the Declaration of Helsinki, and approved by the Research Ethics Committee of Fujian Cancer Hospital.
: Not applicable.
: The authors declare no competing interests.